When Science magazine named cancer immunotherapy the 2013 “Breakthrough of the Year” last December, we knew that it was not only an affirmation of what we have been dedicated to for more than six decades, but that it would be the beginning of an exciting new era in cancer treatment. This past year served as a testament of the accelerated progress being made in the field of cancer immunotherapy research, which would not be possible without the accomplishments here at the Cancer Research Institute.
Some highlights from this year include:
Learn more about our programs and the advancements we’ve made this year.
View our 2014 Annual Report
WSJ Profiles ‘Super Survivors’
Read Previous Article
CRI 2014 Annual Report Highlights
Read Next Article
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
This September for Childhood Cancer Awareness Month, we look at new research, new treatments, and how we are working toward a future immune to childhood cancer.
This September for Gynecologic Cancer Awareness Month, we reflect on new treatments, research discoveries, and how CRI is making its impact on a future immune to cervical, ovarian, and uterine cancers.